文献速递眼底病与葡萄膜炎青光眼角膜与眼表疾病

家族性转甲状腺素蛋白淀粉样变性的眼部表现

Ocular Manifestations of Familial Transthyretin Amyloidosis.
PubMed 文献 · Am J Ophthalmol · 2017-09-11

该观察性病例系列纳入1970年1月1日至2014年11月1日在梅奥诊所就诊的263例转甲状腺素蛋白(TTR)淀粉样变性患者,其中54例在全身症状出现后平均4.25±3.93个月接受眼科检查。108只受检眼中26只眼(24%,来自13例患者)有眼部受累,玻璃体淀粉样变为最常见表现;有眼部受累者女性比例更高且初诊视力更差,10例因明显玻璃体淀粉样变行玻璃体切除术者视力显著改善。

要点

  • 54例TTR淀粉样变性患者108只受检眼中,26只眼(24%)有眼部受累,玻璃体淀粉样变占26/26(100%)。
  • 有眼部受累者女性比例为46% vs 无眼部受累者15%(P=0.008),初诊视力更差(logMAR 0.24 vs 0.00,P=0.017)。
  • 10例因明显玻璃体淀粉样变行玻璃体切除术,视力从基线logMAR 0.70改善至logMAR 0.05(P=0.003)。

核心结论

  • 在这一大型TTR淀粉样变性队列中,女性性别和视力下降与眼部淀粉样变相关。
  • 描述了三种既往未报告与玻璃体受累相关的突变:Glu89Lys、Gly47Arg和纯合Gly6Ser。

研究设计与样本

  • 观察性病例系列,纳入1970年1月1日至2014年11月1日在梅奥诊所就诊并同意加入血液科维护的梅奥诊所淀粉样变性数据库的263例TTR淀粉样变性患者。
  • 其中54例在全身症状出现后平均4.25±3.93个月接受眼科检查,共检查108只眼。

主要发现

  • 108只受检眼中26只眼(24%,来自13例患者)有眼部受累。
  • 有眼部受累者女性比例为46% vs 无眼部受累者15%(P=0.008)。
  • 有眼部受累者初诊视力为logMAR 0.24(Snellen等效20/30)vs 无眼部受累者logMAR 0.00(Snellen等效20/20),P=0.017。
  • 眼部表现包括玻璃体淀粉样变26/26(100%)、神经营养性角膜炎2/26(8%)、青光眼5/26(19%)和视网膜血管迂曲4/26(15%)。
  • 青光眼分类为开角型2/26、剥脱性2/26和淀粉样变所致视网膜中央静脉阻塞后的新生血管性青光眼1/26。

关键数值与推荐

  • 10例因明显玻璃体淀粉样变行玻璃体切除术,视力从基线logMAR 0.70(Snellen等效20/100)改善至logMAR 0.05(Snellen等效约20/20),P=0.003。
  • Glu89Lys、Gly47Arg和纯合Gly6Ser三种突变与玻璃体淀粉样变相关,此前未见描述。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Among patients with familial amyloidosis, mutation in the transthyretin (TTR) protein is the most common type. Patients with TTR amyloidosis have been noted to have ocular, especially vitreous, involvement. In this report, an analysis of the types and frequency of ocular manifestations in TTR amyloidosis is presented. DESIGN: Observational case series. METHODS: Two hundred and sixty-three patients who presented to Mayo Clinic with TTR amyloidosis between January 1, 1970, and November 1, 2014, consented to be included in the Mayo Clinic amyloidosis database maintained by the Department of Hematology. Fifty-four patients had ocular examinations at a mean of 4.25 ± 3.93 months after systemic symptoms. RESULTS: Of 108 examined eyes in 54 patients with TTR amyloidosis, there were 26 eyes (24%) in 13 patients with ocular involvement. Patients with ocular involvement were more likely to be women than those without ocular involvement (46% vs 15%, respectively, P = .008) and have significantly worse visual acuity (VA) at presentation (logMAR 0.24 [Snellen equivalent 20/30] vs logMAR 0.00 [Snellen equivalent 20/20], P = .017). The ophthalmic findings included vitreous amyloid (26/26, 100%), neurotrophic keratitis (2/26, 8%), glaucoma (5/26, 19%), and tortuous retinal vessels (4/26, 15%). The glaucoma was classified as open-angle (2/26), exfoliative (2/26), and neovascular following central retinal vein occlusion from amyloidosis (1/26). Ten patients underwent vitrectomy for visually significant vitreous amyloidosis, which significantly improved VA from a baseline of logMAR 0.70 (Snellen equivalent 20/100) to logMAR 0.05 (Snellen equivalent ∼20/20), P = .003. Three TTR mutations, Glu89Lys, Gly47Arg, and homozygous Gly6Ser, not previously described, were associated with vitreous amyloid. CONCLUSION: In this large cohort of patients with TTR amyloidosis, female sex and decreased VA were associated with ocular amyloid. Three mutations that have not been previously reported to have vitreous involvement were described: Glu89Lys, Gly47Arg, and homozygous Gly6Ser.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Reynolds MM, Veverka KK, Gertz MA, et al. Ocular Manifestations of Familial Transthyretin Amyloidosis. Am J Ophthalmol. 2017. PMID: 28911993. doi:10.1016/j.ajo.2017.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。